Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

420 with CNW — Daily Marijuana Use Has Now Overtaken Alcohol Use in the US

According to a recent survey, the number of Americans who use marijuana daily or almost daily has increased relative to those who use alcohol at the same frequency. The findings, which have been published in the “Addiction Journal,” are based on information gathered over the previous 40 years by the National Survey on Drug Use and Health.

According to the report, 17.7 million people used cannabis daily in 2022, overtaking the 14.7 million people who drink alcohol every day for the first time. Although alcohol is still consumed more frequently overall, the survey shows that daily cannabis consumption has significantly increased over the past few decades.

In particular, there was a 15-fold increase in the number of individuals consuming cannabis every day, or almost every day, between 1992 and 2022. Less than a million people reported using it frequently in 1992, which was the lowest number since the survey’s inception in 1979.

The chief medical officer of the medicinal cannabis startup EO Care, Dr. Brooke Worster, noted that although there are more users now for a variety of reasons, more people are freely confessing to using cannabis as a result of the stigma around it being lessened. According to Worster, the rates haven’t changed as drastically as the survey suggests.

She also noted that more than the previous 20 years, the legal marijuana market has expanded dramatically, drawing a wide variety of users, including a large number of senior citizens.

Currently, 24 states and DC allow the recreational use of cannabis, and 38 states allow it for medical use. Despite this, the federal government has been hesitant to decriminalize or fully legalize cannabis nationally.

However, a major shift occurred recently when the U.S. Department of Justice (DOJ) moved to reclassify marijuana from Schedule I of the the Controlled Substances Act (CSA) to Schedule III. President Joseph Biden acknowledged the need for reform, stating that too many lives have been destroyed by a misguided approach to cannabis.

Worster also addressed the misconception that cannabis acts as a “gateway” drug leading to the use of more dangerous substances. Decades of medical research have debunked this myth, showing that the majority of marijuana users do not progress to harder substances. Nonetheless, she cautioned that young adults and users of high-potency cannabis products are at higher risk of developing marijuana-use disorder.

Marijuana-use disorder can result in serious health and social problems that affect a person’s safety and quality of life, but it does not cause organ destruction or death such as opioid and alcohol-use disorders do.

The increasing daily use of marijuana by Americans suggests that licensed entities such as Tilray Brands Inc. (NASDAQ: TLRY) (TSX: TLRY) could potentially see their sales grow steadily as more people become comfortable about using marijuana either for medicinal or recreational purposes.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Republic of South Africa President Signs Bill Legalizing Marijuana

The president of South Africa has formally signed a measure making adult use, growing and possession of cannabis legal. Just one day before the national elections, President Cyril Ramaphosa signed the Cannabis for Private Purposes Act (CfPPA) into law. The National Council of Provinces gave its support to the bill in February after it was enacted by the National Assembly in November 2023.

This legislative change has been in development for several years, beginning with a 2018 Constitutional Court ruling that declared the ban on marijuana cultivation and simple possession unconstitutional, requiring legislative amendments in two years. Although the bill to legalize cannabis was introduced in 2020, progress was slow despite the government’s intention to prioritize the cannabis sector for economic growth.

The president’s office announced in a news statement that the CfPPA will result in important regulatory changes, such as the exclusion of marijuana from the Drugs and Drug Trafficking Act. To support the industrialization of the marijuana sector, this modification will also enable changes to the Plant Breeders Rights Act, the Medicines and Related Substances Act and the Plant Improvement Act, among other laws.

The office went on to say that the bill shields children from needless exposure while offering rules for medical cannabis use for youth. It ensures that minors’ best interests are taken into consideration by providing an alternate method for resolving instances involving the unlawful use, possession or sale of cannabis. The bill also strictly prohibits the commercial sale of cannabis.

Adults are required by the new regulation to cultivate their cannabis plants and to exclusively use them inside their own homes. Furthermore, prior convictions for cannabis possession and growing may be expunged under the legislation.

Speaking on behalf of the parliament, Moloto Mothapo stated that the government hopes that the measure will open the door for further rules that will aid in the growth of the legal cannabis industry in South Africa.

President Ramaphosa outlined his plan for South Africa to join the global medical cannabis and hemp markets in his 2022 State of the Nation speech, estimating that this might generate more than 100,000 jobs. However, the main goal of the present law is to decriminalize cannabis per the 2018 court verdict, which was made in response to a decision made by a lower court in the province of the Western Cape.

As in South Africa, the Supreme Court in Mexico declared in 2018 that the prohibition of marijuana is unconstitutional, forcing legislators to amend the legislation. Mexico has not yet fully implemented the reform despite recent sessions seeing some progress in this area.

The signs of the wave triggering change in marijuana policy in Africa as well suggests that major entities such as TerrAscend Corp. (TSX: TSND) (OTCQX: TSNDF) could in future have global markets to serve as the trade in this hitherto outlawed substance becomes more commonplace.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

CannabisNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Completes Cargo Management Group Acquisition, Focuses on Long-Term Shareholder Value

Golden Triangle Ventures (OTC: GTVH), a multifaceted consulting company, has completed the acquisition of Cargo Management Group, a multifaceted logistics and trucking operation. According to the announcement, the transaction involved using 10% of the profits from GTVH’s logistics business to buy back and retire GTVH stock, which effectively reduced the number of outstanding shares on a consistent basis as profits are realized. This move represents Golden Triangle Ventures focus on driving long-term value for its shareholders. The company noted that Cargo Management Group reported nearly $3 million in revenue for 2023; the acquisition is expected to streamline internal operations, yield significant cost savings and bolster cash flow, thereby enhancing the Golden Triangle’s business margins. “This initiative marks the first of several strategies we plan to implement that aim to optimize our capital structure within GTV,” said Golden Triangle Ventures president Steffan Dalsgaard in the press release. “Our goal is to develop true fundamental business activities that support all of our operations. We have successfully implemented the first part of our four-pillar business model that supports Lavish Entertainment and our flagship Destino Ranch project, and our team is now focused on executing a series of other promising developments. These efforts are designed to further our objective of increasing shareholder value across all facets of our company.”

To view the full press release, visit https://cnw.fm/8X6q8

About Golden Triangle Ventures Inc.

Golden Triangle Ventures is a multifaceted consulting company, which operates as the parent business pursuing ventures in the health, entertainment and technology sectors along with others that provide synergistic value to these three core divisions. The company aims to purchase, acquire and/or joint venture with established entities within these areas of business. The goods and services represented are driven by innovators who have passion and commitment in these marketplaces. The company plans to utilize relationships and create a platform for new and existing businesses to strengthen its products and/or services. The three points of the Golden Triangle exclusively represent the three sectors the company aims to do business in. Golden Triangle Ventures is highly focused on acquiring a well-diversified portfolio of companies under one umbrella, which are all managed and owned by the company. An amazing team of professionals support each division and continue to help Golden Triangle Ventures grow daily. For more information about the company, please visit www.GoldenTriangleInc.com.

NOTE TO INVESTORS: The latest news and updates relating to GTVH are available in the company’s newsroom at https://cnw.fm/GTVH

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

Alternative Products Expo to Showcase Tradeshow At Houston

Cultivators, manufacturers, entrepreneurs, traders, and enthusiasts, are invited to attend the Alternative Products Expo being held June 20-22, 2024, at the George R. Brown Center, in Houston. With its dynamic vibe of food, culture, art, and pulsating nightlife, Houston is the perfect venue for the Alternative Products Expo.

The Altpro Expo in Houston is hosted by USA CBD Expo, America’s leading CBD and Hemp Expo event organizers. Over recent years, they have expanded to include the full alternative products range ecosystem. Organized by ZJ Events, the Expo caters to the industry’s best CBD traders, manufacturers, and enthusiasts offering an exciting learning experience under a common arena.

With the Houston smoke shop scene in full swing, this year’s Expo is expected to showcase over 500 smoke shops, with numbers rising every year. Both emerging and seasoned brands benefit tremendously by exhibiting their products and services to the Expo’s crowd of enthusiastic audiences.

The Alternative Products Expo offers a phenomenal networking opportunity, where industry people can connect and collaborate with leading brand experts and manufacturers for long-term ROI. Attendees will discover the latest trends and novel ideas currently leading the industry. Exhibitors can showcase their unique offerings to grab a bigger share of the market. Traders can leverage the best show deals as fresh products are introduced with limited-time offers. Also, get updated on the latest regulations and learn the future course of the Alternative Products markets.

Trinity Hemp is the presenting sponsor of Alternative Products Expo Houston.

To learn more, please visit https://cnw.fm/cCKMY

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

Lexaria Bioscience Corp. (NASDAQ: LEXX) Grows Patent Portfolio to 43 Granted Patents Worldwide

  • Lexaria recently received two new patents granted in the U.S. in its patent families #21 and #24
  • The new patents complement the company’s efforts in investigating the capabilities of DehydraTECH-CBD to lower blood pressure in humans with hypertension and mitigate epileptic seizures in rodents
  • The company relies on R&D to provide data that enables it to apply for patent protection, supports further investigations and discoveries, as well as increases its chances of potentially receiving FDA approvals
  • According to CEO Chris Bunka, the company’s growing patent portfolio forms the foundation upon which the company forges commercial relationships

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, started 2024 with a portfolio of 38 patents granted worldwide, having received ten new granted patents during 2023, the most yet in a single year. That patent portfolio, company CEO Chris Bunka explained in his 2024 letter to shareholders, provides vital support for Lexaria’s commercialization efforts as it forms “the foundation upon which future commercial relationships are built.” Yet, according to the letter, the company continues to expect additional patents to be awarded in the future and retains many valid patent applications throughout the world (https://cnw.fm/Bb3nv).

This year, the company has received five new patents, growing its portfolio to 43 granted patents worldwide. This follows the April receipt of three new patents and the most recent announcement of two important new patent awards captured in a May 2024 news release.

According to the announcement, Lexaria received a new granted patent in its patent family #21: Compositions and Methods for Treating Hypertension. This is the company’s third granted U.S. patent in this patent family. Lexaria also reported the receipt of a new granted patent in its patent family #24: Compositions and Methods for Treating Epilepsy. This is the company’s third granted U.S. patent in this patent family (https://cnw.fm/6eFfU).

The company’s growing list of granted patents results from early and ongoing R&D. According to Mr. Bunka, Lexaria uses study-dependent data from studies to confidently support its patent applications. But besides serving the “purpose of allowing us to more confidently apply for patent protection using the study-dependent data,” the studies provide data to potentially support further investigations and discoveries, as well as potential approvals by the U.S. Food and Drug Administration (“FDA”).

This approach, coupled with the long-term vision, has enabled the company to investigate the capabilities of various active pharmaceutical ingredients processed using its patented DehydraTECH(TM) drug delivery technology in human and animal studies. For instance, Lexaria has investigated the ability of DehydraTECH-processed cannabidiol (“CBD”) to potentially treat hypertension in humans and mitigate epileptic seizures in rodents. These applications are partly or wholly protected by the recently granted patents.

Lexaria has repeatedly demonstrated that DehydraTECH-CBD has shown an ability to lower blood pressure in both acute dosing in hypertension and over a 5-week study duration. In a series of four hypertension studies, the company evidenced DehydraTECH-CBD’s ability to lower human blood pressure (https://cnw.fm/YuYG6), including in cases where the treatment was administered over an extended period (https://cnw.fm/ukRzo). The fourth study also led to the discovery of a potentially novel mechanism of action of DehydraTECH-CBD (https://cnw.fm/MjOjt).

These positive results encouraged the company to begin the process of seeking approval from the FDA to conduct a Phase 1b randomized, double-blind, placebo-controlled study of the safety, pharmacokinetics, and pharmacodynamics of DehydraTECH-CBD for the treatment of stage 1 or 2 hypertension. The company received earlier this year the FDA clearance to conduct the study (https://cnw.fm/Yo9IO) and will provide updates on the status of this planned study in due course.

Beyond the treatment of hypertension, Lexaria has demonstrated, through an animal study, that DehydraTECH-CBD reduces or eliminates seizure activity in animals and, in some cases, even surpasses the performance of Epidiolex(R), one of the world’s leading anti-seizure medications. The company also reported that DehydraTECH-CBD suppresses body weight, improves triglyceride/cholesterol levels, and reduces blood glucose levels in an animal diabetes study.

The successes of these animal studies have supported the possibility of conducting additional human clinical studies of DehydraTECH-CBD. In addition to investigating DehydraTECH-CBD’s capabilities, Lexaria is also looking at the potential application of its drug delivery technology to GLP-1 drugs.

Supported by a robust growing portfolio of granted patents and encouraged by the positive results from its R&D activities, Lexaria continues to forge ahead, aiming to achieve its future business objectives.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Marijuana Reclassification Could Result in Greener Farming Methods

Could the reclassification of cannabis lead to significant reductions in energy consumption by commercial marijuana cultivators and overall improvement in the industry’s environmental impact?

It’s well-known that indoor marijuana cultivation facilities have a major environmental and energy footprint. This is largely due to the massive electricity consumption required for robust HVAC systems, horticultural lighting, and numerous fans and pumps needed to create optimal growing conditions.

Although the exact details of a post-scheduling cannabis industry in the United States are unknown, we can learn from the controlled-environment agriculture (CEA) industry about potential changes in cannabis growing, such as the adoption of less energy-intensive techniques.

Reclassification could unlock a variety of federal programs that are currently inaccessible to cannabis entities due to federal prohibition.

The Biden administration allocated billions for agricultural and clean-energy projects in 2022 through the Inflation Reduction Act. For instance, the U.S. Department of Agriculture (USDA) has, through loan guarantees and grants, helped domestic CEA enterprises install efficient and sustainable energy technologies. These include chillers, heat pumps, LED grow lights, clean-power generation and sophisticated HVAC systems.

The program works better for larger institutions due to the significant administrative effort associated with applying for USDA assistance.

Nonetheless, CEA companies of all sizes can obtain support navigating USDA grant and loan applications from a number of federal grant aid organizations. The IRS provides a 30% investment tax credit for marijuana companies that want to install renewable energy sources, such as solar panels, on their property.

Developers of cultivation facilities sometimes point to the high upfront costs as a primary deterrent to the installation of cutting-edge, energy-efficient machinery. Rescheduling could free operators from the restrictions imposed by Section 280E of the IRS, which levies greater taxes on corporations that handle plants than on conventional enterprises. This might free up funds, allowing numerous operators to modernize their spaces for increased energy efficiency.

As of right now, indoor facilities are not subject to any national codes; however, this could change in the future when the International Energy Conservation Code is updated. States that enforce clean-air vehicle requirements, such as California, may, in the meantime, implement more stringent regulations than those established by the federal government.

In the meanwhile, multistate cannabis companies will have to manage a complicated web of regulations.

The potential reclassification of cannabis presents a great opportunity to make the industry more environmentally sustainable. It’s imperative that marijuana businesses keep up with constantly changing federal regulations and proactively implement clean, energy-efficient technology.

Compared to outdoor farms or traditional greenhouses, indoor agriculture requires a lot more electricity per square foot yet permits year-round production regardless of the weather. In the event that cannabis becomes legally transferable across state lines, growers may decide to move from costly indoor models in the north to more affordable outdoor or greenhouse settings in the South and west.

Although this transition could take decades, shifting production to more naturally conducive areas would significantly lessen the industry’s overall environmental footprint.

As the anticipated regulatory change is still very much in flux, entities such as SNDL Inc. (NASDAQ: SNDL) are likely to observe and later decide how best to leverage the changed regulatory landscape in order to further optimize their operations.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

CannabisNewsBreaks – Alternative Products Expo Returns to Texas for Flagship Global Counterculture Event

Alternative Products Expo (Alt Pro Expo) is preparing to kick off its next in a series of blowout events across North and South America. Presented by ZJ Evets, Alt Pro Expo is slated for June 20–22, 2024, in Houston, Texas. Through the years, Alt Pro Expo has built a reputation for creating a flagship series of events in the global counterculture industry. The agenda for the networking festival includes invaluable education while the exhibit area spotlights an incredible portfolio of innovative products, including vape and hemp products, CBD, disposables, kratom, mushrooms, functional beverages, dietary supplements, nootropics, nicotine replacement, energy enhancers, mood changers and other accessories. The event offers an unparalleled opportunity for hundreds of top manufacturers, buyers, suppliers, innovators, vendors, researchers, budding entrepreneurs and seasoned industry professionals to gather together. “The Alternative Products Expo is the flagship series for the global counterculture industry and is the preeminent platform for nurturing professional networks, building market presence, and fine-tuning market entry strategies,” said Alt Pro Expo director of partnerships Sebastian Carmona in the press release. “Following the raging success of the Dallas event last year, we are thrilled to be returning to the great state of Texas to help drive participation and innovation in the vape, smoke shop and the broader alternative products sector. The upcoming expo is a must-attend for fresh business owners and vendors, established industry players, enthusiastic consumers, and curious newcomers.”

To attend the event, visit https://cnw.fm/fTtra

To view the full press release, visit https://cnw.fm/WVLn7

About Alternative Products Expo

Alternative Products Expo, formerly USA CBD Expo, is a production of ZJ Events. Company founders were once exhibitors who, after attending countless trade show events, saw an opportunity to build upon their experience and create an event that combined the best they had seen, with their own notion of what was missing in these business gatherings. By bringing the alternative community together, the company seeks to provide industry professionals from all corners of the market with an immersive and unique opportunity for networking and business expansion. For more information about the company, visit www.AltProExpo.com.

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Completion of Dosing in Second Arm of Third GLP-1 Human Pilot Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is reporting that the second round of dosing for all nine study participants in the second arm of its human pilot study #2 has been completed. The company anticipates completion of the final arm of the study, GLP-1-H24-2, in July. A three-arm, crossover investigation that compares three 7 mg semaglutide dose formulations, the study evaluates three doses: a positive control Rybelsus(R) swallowed tablet; DehydraTECH-semaglutide swallowed capsule; and for the first time ever, an in-mouth dissolvable DehydraTECH-semaglutide oral tablet. The study is designed to measure tolerability and side effects as well as semaglutide and blood glucose levels. Rybelsus (semaglutide) is the only GLP-1 drug approved by the FDA for oral dosingto treat diabetes and weight loss. “Blood samples will be taken multiple times during the first 10 hours post dosing,” the company stated in the press release. “A final blood draw will be taken 24 hours after dosing, and a standardized meal will be fed to the test subjects at a point in time after dosing. Nine healthy subjects are expected to be dosed with each test article with roughly a 30-day ‘washout’ interval between each dosing visit.

To view the full press release, visit https://cnw.fm/BZSDc

About Lexaria Bioscience Corp.

Lexaria Bioscience’s patented drug-delivery formulation and processing platform technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream through oral delivery. Since 2016, Lexaria has developed and investigated DehydraTECH with a variety of beneficial molecules in oral and topical formats. DehydraTECH has repeatedly demonstrated the ability to increase bioabsorption and has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier, which Lexaria believes to be of particular importance for centrally active compounds. Lexaria operates a licensed, in-house research laboratory and holds a robust intellectual property portfolio with 43 patents granted and many patents pending worldwide. For more information about the company, please visit www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Study Finds Adolescents’ Use of Marijuana Heightens Psychotic Disorders Risk

A recent study featured in the “Psychological Medicine” journal delves into the relationship between adolescent marijuana use and the development of psychotic disorders. The research indicates a significant increase in psychotic disorder risks during adolescence linked to marijuana use, a risk that is particularly pronounced with the stronger marijuana products available today. Interestingly, this increased risk does not extend into young adulthood.

Previous studies have suggested a link between youth marijuana use and psychotic disorders, noting a higher likelihood of such disorders among marijuana users. These earlier studies often relied on outdated data when marijuana was less potent and faced limitations such as small sample sizes and less clinically significant outcomes.

The recent study assessed the relationship between teenage marijuana usage and the likelihood of receiving a clinical diagnosis of a psychotic condition using more recent population-based statistics. The goal of the research was to bring the findings up to speed with the current increase in marijuana potency.

Data were drawn from the Canadian Community Health Survey (CCHS) between 2009 and 2012, linked with Ontario’s administrative health records. The study focused on Ontario residents aged 12 to 24 years of age. Those with incomplete medical records or a history of psychotic disorders were excluded, resulting in a final sample of 11,363 participants.

Information on marijuana use and other substance usage, along with sociodemographic details was collected through interviews conducted both by phone and in person. The follow-up ended in 2018 after a maximum of nine years of monitoring the participants. The analysis accounted for various confounding factors, including sex, age, race, other drug use and income.

Approximately 23.4% of respondents reported using marijuana in the past 12 months, and during the follow-up, 1.2% sought healthcare for psychotic disorders. The analysis revealed a significant association between psychotic disorders and recent marijuana use among adolescents aged 12 to 19 years of age, with an adjusted hazard ratio of 11.21. This was not found in young adults aged 20 to 33 years of age, who had an aHR of 1.29.

Subsequent analysis supported these results, demonstrating an aHR of 26.68 for adolescent cannabis users’ hospitalizations or doctor visits linked to psychotic illnesses. Additionally, a dose-response association was noted, with an aHR of 10.70 indicating that frequent marijuana use among teenagers was associated with a higher risk. An analysis focusing on gender revealed that this link, with an aHR of 9.98, was significant for teenage males.

Additionally, the study discovered a substantial correlation between cannabis usage in the year prior and the utilization of healthcare services for psychotic disorders in the past, indicating a possible reverse causal relationship.

The study’s strengths include the use of representative and high-quality data from the CCHS and linked health records, as well as a validated outcome measure and recent cannabis potency data. However, limitations include a single baseline assessment, self-reported marijuana use, and possible unmeasured confounding measures including family history, trauma and genetic predispositions.

These findings hold important implications for public policy and health, especially concerning the prevention of teenage marijuana use.

This elevated risk of adolescents developing psychosis when they use marijuana makes a strong case for allowing legal marijuana sales by licensed companies such as Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) in states because guardrails, including verifying the age of a product buyer, can be implemented to make it harder for teens to access marijuana.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

CannabisNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Completes Strategic Acquisition

Golden Triangle Ventures (OTC: GTVH) (“GTV”) today announced the successful completion of its acquisition of Cargo Management Group, a reputable and longstanding shipping, logistics and trucking operation, from TK Zarro, LLC. The acquisition marks a significant milestone in GTV’s expansion efforts, as well as enhancing its operational capabilities within its Lavish Entertainment division and providing a full suite of in-house logistics capabilities for other company operations. Cargo Management Group reported nearly $3 million in revenue for 2023 and brings a robust portfolio of contracts with industry leaders such as JB Hunt, CH Robinson, Coyote Logistics, and Echo Logistics. “The acquisition of Cargo Management Group is a transformative step for GTV. This deal provides a scalable business model that will support both Lavish Entertainment and the development of our future flagship project, Destino Ranch,” said Steffan Dalsgaard, CEO of Golden Triangle Ventures. “This business, its income, and our recently completed renegotiations on our outstanding note will dramatically impact our balance in a positive manner. Additionally, this helps move GTV toward its goal of becoming a highly profitable company with minimal to zero debt and a diverse asset portfolio.”

To view the full press release, visit https://cnw.fm/xlWw2

About Golden Triangle Ventures Inc. (“GTV”)

Golden Triangle Ventures is a multifaceted consulting company, which operates as the parent business pursuing ventures in the health, entertainment and technology sectors, along with others that provide synergistic value to these three core divisions. The company aims to purchase, acquire and/or joint venture with established entities within these areas of business. The goods and services represented are driven by innovators who have passion and commitment in these marketplaces. The company plans to utilize relationships and create a platform for new and existing businesses to strengthen their products and/or services. The three points of the Golden Triangle exclusively represent the three sectors in which this company aims to do business. Golden Triangle Ventures is highly focused on acquiring a well-diversified portfolio of companies under one umbrella, which are all managed and owned by the company. An amazing team of professionals support each division and continue to help the company grow daily. Being a publicly traded company gives the ability to provide the support needed to help each subsidiary grow into the business that management believes it can and will become. For more information, visit the company’s website at www.GoldenTriangleInc.com.

NOTE TO INVESTORS: The latest news and updates relating to GTVH are available in the company’s newsroom at https://cnw.fm/GTVH

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN